Enhanced ERK1/2 activity, achieved through deletion of its phosphatases DUSP6/8, leads to resistance to diet-induced obesity, improved glucose tolerance, and reduced serum triglycerides and lipid content in the liver and visceral adipose tissues [26]. The gene discussed is MAPK3; the disease is obesity disorder.